Nucleic acid triggered catalytic drug and probe release
The present invention provides methods and combinations of compositions for the modulation of diseases caused by a subject possessing a disease-specific nucleic acid sequence. Included are methods for the treatment, prevention and/or inhibition of the diseases by administering a combination of a pro...
Saved in:
| Main Author | |
|---|---|
| Format | Patent |
| Language | English |
| Published |
27.03.2003
|
| Online Access | Get full text |
Cover
Loading…
| Summary: | The present invention provides methods and combinations of compositions for the modulation of diseases caused by a subject possessing a disease-specific nucleic acid sequence. Included are methods for the treatment, prevention and/or inhibition of the diseases by administering a combination of a prodrug component, drug and catalytic component such that the drug is catalytically released when contacting the combination to the disease-specific nucleic acid sequence. |
|---|